Efficacy of subcutaneous preemptive rituximab in immune-mediated thrombotic thrombocytopenic purpura: Experience from the first 12 cases.
Maxime DelrueMinh Tam BaylatryAnne-Christine JolyElise CorreZora MarjanovicNoujoud El-Khoury-HannaFrédéric FégerLudovic SunerAgnès VeyradierAlain StépanianPaul CoppoPublished in: American journal of hematology (2020)